PerpEquities

Pfizer Inc. (PFE) balance sheet

NYSE · Healthcare · Drug Manufacturers - General · 75,000 employees · CEO Albert Bourla

Price
$30.52 +1.90%
Market cap
$174B
Enterprise value
$236B
Last report
Q2 '26 filed 2026-08-04
Next report
2026-11-03 EPS est. $0.73

At the end of Q2 '26 Pfizer Inc. (PFE) held $11.7B in cash and short-term investments against $63.2B of debt incl. leases. Total assets $201B, total liabilities $116B, shareholders' equity $85.2B.

Balance sheet

Balance sheetTrendQ3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26
Assets
Cash & equivalents$3.15B$2.85B$719M$1.05B$1.09B$1.04B$1.43B$1.64B$1.34B$1.14B$1.7B$976M
Short-term investments$41B$9.84B$11.2B$6.05B$8.86B$19.4B$15.9B$11.6B$13.6B$12.5B$11.4B$10.7B
Receivables$15B$15.5B$15.2B$15.1B$17.7B$14.8B$14.7B$16.1B$18.1B$15.8B$12.6B$12.5B
Inventory$10.2B$10.2B$10.9B$11.4B$11.7B$10.9B$10.9B$11.7B$11.5B$10.7B$10.7B$9.95B
Other current assets$4.62B$4.91B$4.37B$4.19B$3.86B$4.25B$2.95B$2.69B$2.36B$2.81B$2.91B$7.22B
Current assets$74B$43.3B$42.4B$37.8B$43.2B$50.4B$45.9B$43.7B$46.9B$42.9B$42.8B$41.4B
Property, plant & equipment (net)$17.9B$18.9B$18.8B$19B$18.5B$18.4B$18.3B$18.8B$18.9B$21.5B$19.4B$19B
Long-term investments$14.2B$15.4B$11.6B$11.1B$10.8B$2.23B$2.01B$224M$2.14B$1.74B$1.63B$1.56B
Goodwill$51.5B$67.8B$69.3B$68.4B$68.6B$68.5B$68.4B$69B$69.1B$71.3B$71.4B$71.4B
Intangible assets$40.2B$64.9B$62.8B$61.2B$60B$55.4B$54B$52.7B$51.3B$53.7B$52.6B$47.1B
Deferred tax assets$8.35B$3.71B$4.94B$7.87B$7.91B$8.66B$9.54B$10.3B$11B$9.7B$9.97B$10.8B
Other non-current assets$8.39B$12.5B$11.2B$10.7B$10.5B$9.82B$9.85B$11.4B$9.32B$7.3B$9.84B$9.94B
Non-current assets$141B$183B$179B$178B$176B$163B$162B$162B$162B$165B$165B$160B
Total assets$215B$227B$221B$216B$219B$213B$208B$206B$209B$208B$208B$201B
Liabilities
Accounts payable$5.34B$6.71B$5.59B$5.11B$5.31B$5.63B$5.24B$5.17B$5.02B$5.24B$4.51B$4.58B
Accrued expenses$0$0$0$0$0$0$0$0$3.04B$3.61B$2.72B$2.55B
Short-term debt$2.55B$10.3B$8.23B$11.9B$9.7B$6.95B$4.47B$4.3B$4.3B$3.48B$3.89B$2.7B
Taxes payable$1.9B$2.35B$3.19B$2.88B$2.88B$2.91B$0$3.68B$3.8B$0$3.13B$653M
Deferred revenue$2.2B$2.7B$2.5B$2.53B$2.02B$1.51B$1.01B$1.12B$924M$784M$646M$0
Other current liabilities$19.1B$23.3B$21B$19B$23.3B$23.6B$22.6B$23.5B$19.5B$20.8B$19.5B$22.8B
Current liabilities$31.1B$47.8B$40.5B$43.8B$43.2B$43B$36.5B$37.7B$36.6B$37B$34.3B$32.6B
Long-term debt$61B$60.5B$60.5B$56.7B$56.9B$56.7B$56.8B$57.5B$57.4B$61.6B$60.6B$60.5B
Lease obligations (non-current)$0$0$0$0$0$0$0$0$0$2.29B$0$0
Deferred tax liabilities$1.13B$640M$931M$2.23B$2.16B$2.12B$2.26B$2.48B$2.47B$2.4B$2.41B$1.96B
Other non-current liabilities$24.5B$28.3B$26.6B$25.4B$24.6B$23.1B$21.9B$19.4B$19.2B$18.1B$19.9B$20.5B
Non-current liabilities$86.7B$89.4B$88B$84.4B$83.7B$81.9B$80.9B$79.4B$79B$84.4B$82.9B$83B
Total liabilities$118B$137B$129B$128B$127B$125B$117B$117B$116B$121B$117B$116B
Equity
Common stock & paid-in capital$478M$478M$480M$480M$480M$480M$481M$481M$481M$481M$482M$482M
Retained earnings$126B$118B$121B$117B$121B$117B$120B$118B$121B$115B$117B$112B
Accumulated other comprehensive income-$7.97B-$7.96B-$7.76B-$7.82B-$7.97B-$7.84B-$8.58B-$8.44B-$8.07B-$8.07B-$7.2B-$7.22B
Shareholders' equity$96.9B$89B$92.3B$87.7B$92.3B$88.2B$90.3B$88.7B$92.8B$86.5B$90.1B$85.2B
Debt
Total debt (incl. leases)$63.6B$70.8B$68.7B$68.7B$66.6B$63.6B$61.3B$61.8B$61.7B$67.4B$64.5B$63.2B
Net debt (debt - cash)$60.4B$68B$68B$67.6B$65.5B$62.6B$59.9B$60.2B$60.4B$66.3B$62.8B$62.2B

Standardised by Financial Modeling Prep from the company's filings; outflows and costs keep the sign the provider reports. Hover a period for its end date. Amounts in USD.

Cash, investments and debt

quarter ends

The other statements

Sources

Statements, segment revenue, metrics, estimates: Financial Modeling Prep. Segment profits and every reported line: SEC EDGAR (XBRL). Filings read: 10-Q 2026-06-28, 10-Q 2026-03-29, 10-K 2025-12-31, 10-Q 2025-09-28, 10-Q 2025-06-29, 10-Q 2025-03-30, 10-K 2024-12-31, 10-Q 2024-09-29, 10-Q 2024-06-30

Data as of 2026-11-01